Eli Lilly & Co. Shares Newsletter
-
Jim Cramer's week ahead: Earnings from Amazon, Alphabet, Eli Lilly, Palantir
01 Feb 2025 04:25 GMT
… reports from Amazon, Alphabet, Eli Lilly and Palantir, as well as … from more drug stocks, Eli Lilly and Bristol Myers Squibb, … needs more details from Eli Lilly that suggest next year … Charitable Trust holds shares of Amazon, Alphabet, Eli Lilly, Walt Disney …
-
Eli Lilly Stock: What Investors Should Watch in 2025
29 Jan 2025 12:03 GMT
… as Mounjaro and Zepbound), Eli Lilly (NYSE:LLY) was another … popularity of these treatments. Eli Lilly saw Mounjaro sales climb … of supply.
Nonetheless, shares of Eli Lilly have been erratic in … keep in mind that Eli Lilly still projects substantial top …
-
Billionaire Investor Philippe Laffont Shifts Focus from Tech to Weight-Loss Drugs
01 Feb 2025 21:35 GMT
… investments in pharmaceutical leaders Eli Lilly and Novo Nordisk. The … Eli Lilly holdings by 19%, bringing his total to 247,950 shares … loss drug market, with Eli Lilly selling Mounjaro and Zepbound … is growing rapidly.” Eli Lilly recently secured approval for …
-
Veru shares plunge despite positive data in obesity trial
28 Jan 2025 14:01 GMT
… decline in Veru's shares despite the positive result may … category, although, other companies including Eli Lilly through its 2023 acquisition of …
-
Pfizer shares positive late-stage results for Braftovi regimen in colorectal cancer
27 Jan 2025 12:45 GMT
Pfizer has shared positive results from a late-stage study of its Braftovi (encorafenib) combination in BRAF V600E-mutant metastatic colorectal cancer (mCRC).
The ongoing phase 3 BREAKWATER trial has been evaluating the drug in combination with Eli Lilly…
-
Stocks Jump In January Amid Solid Macro Data, Strong Earnings
01 Feb 2025 02:00 GMT
… performance, driven by rebounds in Eli Lilly, UnitedHealth Group, and Johnson … beneficial long position in the shares of AGG, IBIT either through …
-
ResMed revenue up 10% in Q2 — but GLP-1 questions remain
31 Jan 2025 19:19 GMT
… month after the FDA approved Eli Lilly’s GLP-1 drug Zepbound … consumer tech, Farrell said.
RMD shares were down more than 6% … rating of the company’s shares at Hold, citing GLP-1s …
-
Two more biotechs, Metsera and Maze, cross IPO finish line
31 Jan 2025 18:35 GMT
… just under 15.3 million shares and the underwriters have the … buy another 2.3 million shares within the next 30 days … meanwhile sold 8.75 million shares at $16 apiece, with another … dominated by Novo Nordisk and Eli Lilly, but likely to get considerably …
-
AbbVie (ABBV) Earnings Live: Why The Stock Is Up Big Today
31 Jan 2025 17:19 GMT
… 2024, expanding next-gen therapies.
Shares of AbbVie (NYSE:ABBV) are … second to only fellow drugmaker Eli Lilly (NYSE:LLY), which trades at …
-
ResMed Inc. (NYSE:RMD) Q2 2025 Earnings Call Transcript
31 Jan 2025 13:41 GMT
… its launch to consumers, Eli Lilly’s early educational documents that … purchased approximately 307,000 shares under our previously authorized share … to continue to purchase shares to the value of … the new Zepbound indication in Eli Lilly, they just got their …